Huaren Pharmaceutical Co.,Ltd.’s Net Profit Rose 2.2% in First Quarter of 2022

Huaren Pharmaceutical Co.,Ltd. (华仁药业股份有限公司) (300110.SZ) reported a net profit of 26.2 million yuan in the first quarter of 2022, up 2.2% year-on-year.

Meanwhile, the company posted 385.5 million yuan in revenue, up 12.3% year-on-year.

At the end of the reporting period, it had 5.3 billion yuan in total assets and 2.9 billion yuan in total liabilities, with a liability-to-asset ratio of 53.8%.